Artificial intelligence for telemedicine diabetic retinopathy screening: a review

References

• Ryu S. Telemedicine: opportunities and developments in member states: report on the Second Global Survey on eHealth 2009 (Global Observatory for eHealth series, volume 2). Healthc Inform Res. 2012;18(2):1. doi: 10.4258/hir.2012.18.2.153.
   PubMedGoogle Scholar
• Scott Kruse C, Karem P, Shifflett K, et al. Evaluating barriers to adopting telemedicine worldwide: a systematic review. J Telemed Telecare. 2018;24(1):4–9. doi: 10.1177/1357633X16674087.
   PubMed Web of Science ®Google Scholar
• Mun SK, Turner JW. Telemedicine: emerging e-medicine. Annu Rev Biomed Eng. 1999;1(1):589–610. doi: 10.1146/annurev.bioeng.1.1.589.
   PubMedGoogle Scholar
• Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20(1):1193. doi: 10.1186/s12889-020-09301-4.
   PubMed Web of Science ®Google Scholar
• Thomas-Jacques T, Jamieson T, Shaw J. Telephone, video, equity and access in virtual care. NPJ Digit Med. 2021;4(1):159. doi: 10.1038/s41746-021-00528-y.
   PubMed Web of Science ®Google Scholar
• Kruse CS, Krowski N, Rodriguez B, et al. Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open. 2017;7(8):e016242. doi: 10.1136/bmjopen-2017-016242.
   PubMed Web of Science ®Google Scholar
• Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi: 10.2337/dc11-1909.
   PubMed Web of Science ®Google Scholar
• Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–277. doi: 10.1111/ceo.12696.
   PubMed Web of Science ®Google Scholar
• Tan GS, Cheung N, Simó R, et al. Diabetic macular oedema. Lancet Diabetes Endocrinol. 2017;5(2):143–155. doi: 10.1016/S2213-8587(16)30052-3.
   PubMed Web of Science ®Google Scholar
• Hutchinson A, McIntosh A, Peters J, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy – a systematic review. Diabet Med. 2000;17(7):495–506. doi: 10.1046/j.1464-5491.2000.00250.x.
   PubMed Web of Science ®Google Scholar
• Saha SK, Fernando B, Cuadros J, et al. Automated quality assessment of colour fundus images for diabetic retinopathy screening in telemedicine. J Digit Imaging. 2018;31(6):869–878. doi: 10.1007/s10278-018-0084-9.
   PubMed Web of Science ®Google Scholar
• Lim JI, Regillo CD, Sadda SR, et al. Artificial intelligence detection of diabetic retinopathy: subgroup comparison of the EyeArt system with ophthalmologists’ dilated examinations. Ophthalmol Sci. 2023;3(1):100228. doi: 10.1016/j.xops.2022.100228.
   PubMedGoogle Scholar
• Abràmoff MD, Lavin PT, Birch M, et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. 2018;1:39. doi: 10.1038/s41746-018-0040-6.
   PubMed Web of Science ®Google Scholar
• Ipp E, Liljenquist D, Bode B, et al. Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy. JAMA Netw Open. 2021;4(11):e2134254. doi: 10.1001/jamanetworkopen.2021.34254.
   PubMed Web of Science ®Google Scholar
• Horton MB, Brady CJ, Cavallerano J, et al. Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, third edition. Telemed J E Health. 2020;26(4):495–543. doi: 10.1089/tmj.2020.0006.
   PubMed Web of Science ®Google Scholar
• World Bank Country and Lending Groups – World Bank Data Help Desk; 2022 [cited 2022 Dec 29]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519
   Google Scholar
• Hejlesen O, Ege B, Englmeier K-H, et al. TOSCA-Imaging – developing internet based image processing software for screening and diagnosis of diabetic retinopathy. Stud Health Technol Inform. 2004;107:222–226.
   PubMedGoogle Scholar
• Schneider S, Aldington SJ, Kohner EM, et al. Quality assurance for diabetic retinopathy telescreening. Diabet Med. 2005;22(6):794–802. doi: 10.1111/j.1464-5491.2005.01512.x.
   PubMed Web of Science ®Google Scholar
• Joshi GD, Sivaswamy J. DrishtiCare: a telescreening platform for diabetic retinopathy powered with fundus image analysis. J Diabetes Sci Technol. 2011;5(1):23–31. doi: 10.1177/193229681100500104.
   PubMedGoogle Scholar
• Karnowski TP, Giancardo L, Li Y, et al. Retina image analysis and ocular telehealth: the Oak Ridge National Laboratory-Hamilton Eye Institute case study. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:7140–7143. doi: 10.1109/EMBC.2013.6611204.
   PubMedGoogle Scholar
• Tobin KW, Chaum E, Govindasamy VP, et al. Detection of anatomic structures in human retinal imagery. IEEE Trans Med Imaging. 2007;26(12):1729–1739. doi: 10.1109/tmi.2007.902801.
   PubMed Web of Science ®Google Scholar
• Saeed E, Szymkowski M, Saeed K, et al. An approach to automatic hard exudate detection in retina color images by a telemedicine system based on the d-Eye sensor and image processing algorithms. Sensors. 2019;19(3):695. doi: 10.3390/s19030695.
   PubMed Web of Science ®Google Scholar
• Ogunyem O, Teklehaimanot S, Patty L, et al. Evaluating predictive modeling’s potential to improve teleretinal screening participation in urban safety net clinics. Stud Health Technol Inform. 2013;192:162–165.
   PubMedGoogle Scholar
• Walton OB4th, Garoon RB, Weng CY, et al. Evaluation of automated teleretinal screening program for diabetic retinopathy. JAMA Ophthalmol. 2016;134(2):204–209. doi: 10.1001/jamaophthalmol.2015.5083.
   PubMed Web of Science ®Google Scholar
• Xie Y, Nguyen QD, Hamzah H, et al. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study. Lancet Digit Health. 2020;2(5):e240–e249. doi: 10.1016/S2589-7500(20)30060-1.
   PubMedGoogle Scholar
• Rajalakshmi R, UmaSankari G, Prathiba V, et al. Tele-ophthalmology versus face-to-face retinal consultation for assessment of diabetic retinopathy in diabetes care centers in India: a multicenter cross-sectional study. Diabetes Technol Ther. 2022;24(8):556–563. doi: 10.1089/dia.2022.0025.
   PubMed Web of Science ®Google Scholar
• Habib AR, Lin AL, Grant RW. The epic sepsis model falls short—the importance of external validation. JAMA Intern Med. 2021;181(8):1040–1041. doi: 10.1001/jamainternmed.2021.3333.
   PubMed Web of Science ®Google Scholar
• Wong A, Otles E, Donnelly JP, et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021;181(8):1065–1070. doi: 10.1001/jamainternmed.2021.2626.
   PubMed Web of Science ®Google Scholar
• Adamson AS, Smith A. Machine learning and health care disparities in dermatology. JAMA Dermatol. 2018;154(11):1247–1248. doi: 10.1001/jamadermatol.2018.2348.
   PubMed Web of Science ®Google Scholar
• Bordia S, Bowman SR. Identifying and reducing gender bias in word-level language models. Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics; 2019 Jun 3–5; Minneapolis, MN. doi: 10.18653/v1/N19-3002.
   Google Scholar
• Ruamviboonsuk P, Tiwari R, Sayres R, et al. Real-time diabetic retinopathy screening by deep learning in a Multisite National Screening Programme: a prospective interventional cohort study. Lancet Digit Health. 2022;4(4):e235–e244. doi: 10.1016/S2589-7500(22)00017-6.
   PubMedGoogle Scholar
• Heaven WD. Google’s medical AI was super accurate in a lab. Real life was a different story. Technology review; 2020 [cited 2020 Apr 27; updated 2023 Feb 2]. Available from: https://www.technologyreview.com/2020/04/27/1000658/google-medical-ai-accurate-lab-real-life-clinic-covid-diabetes-retina-disease/
   Google Scholar
• Scotland GS, McNamee P, Philip S, et al. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol. 2007;91(11):1518–1523. doi: 10.1136/bjo.2007.120972.
   PubMed Web of Science ®Google Scholar
• Tufail A, Rudisill C, Egan C, et al. Automated diabetic retinopathy image assessment software: diagnostic accuracy and cost-effectiveness compared with human graders. Ophthalmology. 2017;124(3):343–351. doi: 10.1016/j.ophtha.2016.11.014.
   PubMed Web of Science ®Google Scholar
• Huang X-M, Yang B-F, Zheng W-L, et al. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China. BMC Health Serv Res. 2022;22(1):260. doi: 10.1186/s12913-022-07655-6.
   PubMed Web of Science ®Google Scholar
• Roberts M, Driggs D, Thorpe M, et al. Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans. Nat Mach Intell. 2021;3(3):199–217. doi: 10.1038/s42256-021-00307-0.
   Google Scholar
• Delgado J, de Manuel A, Parra I, et al. Bias in algorithms of AI systems developed for COVID-19: a scoping review. J Bioeth Inq. 2022;19(3):407–419. doi: 10.1007/s11673-022-10200-z.
   PubMed Web of Science ®Google Scholar
• Jacoba CMP, Celi LA, Lorch AC, et al. Bias and non-diversity of Big Data in artificial intelligence: focus on retinal diseases. Semin Ophthalmol. 2023;38(5):433–441. doi: 10.1080/08820538.2023.2168486.
   PubMed Web of Science ®Google Scholar